Blankart, Katharina Elisabeth; Stargardt, Tom - In: Health Economics 29 (2020) S1, pp. 63-82
Payers are increasingly calling for the value of new drugs to be measured explicitly. We analyze how the availability of drug quality ratings by health technology assessment (HTA) agencies affects the adoption of new drugs by physicians in Germany. We combine data from drug quality ratings,...